Literature DB >> 31211984

LncRNA MAFG-AS1 boosts the proliferation of lung adenocarcinoma cells via regulating miR-744-5p/MAFG axis.

Yuan Sui1, Guangyao Lin2, Yinshi Zheng1, Wenqi Huang1.   

Abstract

Lung adenocarcinoma (LUAD) is typically featured by a low 5-year survival rate, hence there is a necessary to investigate new biomarkers in LUAD progression. Competing endogenous RNA (ceRNA) network has been widely reported in the regulation of tumor processes, which is also the main direction of this paper. Based on the data of GEPIA database, lncRNA MAFG-AS1 was upregulated in LUAD tissues, which was associated with poor prognosis of patients. Proliferation or apoptosis of LUAD cells were measured by CCK-8, EdU and caspase-3 activity assays followed by Western blot. The results indicated that silencing of MAFG-AS1 suppressed cell proliferation but induced cell apoptosis. RNA FISH staining showing the cytoplasmic localization of MAFG-AS1 in LUAD cells. Mechanism detection revealed that MAFG-AS1 served as a molecular sponge of miR-744-5p to upregulate its nearby gene MAF bZIP transcription factor G (MAFG) in LUAD cells. Functionally, MAFG overexpression attenuated the cellular processes mediated by MAFG-AS1 knockdown. In summary, this study unveiled the MAFG-AS1/miR-744-5p/MAFG axis in LUAD, providing a potent and promising therapeutic target for LUAD patients.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Lung adenocarcinoma; MAFG; MAFG-AS1; miR-744-5p

Mesh:

Substances:

Year:  2019        PMID: 31211984     DOI: 10.1016/j.ejphar.2019.172465

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  24 in total

1.  MAFG-AS1 is a novel clinical biomarker for clinical progression and unfavorable prognosis in gastric cancer.

Authors:  Chao Li; Rongfang Wu; Youzhong Xing
Journal:  Cell Cycle       Date:  2020-02-20       Impact factor: 4.534

Review 2.  Non-coding RNAs in ferroptotic cancer cell death pathway: meet the new masters.

Authors:  Mehdi Rabiee Valashedi; Chia Bamshad; Nima Najafi-Ghalehlou; Amirsadegh Nikoo; Kazuo Tomita; Yoshikazu Kuwahara; Tomoaki Sato; Amaneh Mohammadi Roushandeh; Mehryar Habibi Roudkenar
Journal:  Hum Cell       Date:  2022-04-12       Impact factor: 4.174

3.  Downregulation of long non-coding RNA MAFG-AS1 represses tumorigenesis of colorectal cancer cells through the microRNA-149-3p-dependent inhibition of HOXB8.

Authors:  Zhiyan Ruan; Hongling Deng; Minhua Liang; Zhe Xu; Manxiang Lai; Hong Ren; Xiangliang Deng; Xinguo Su
Journal:  Cancer Cell Int       Date:  2020-10-19       Impact factor: 5.722

4.  LncRNA MAFG-AS1 Accelerates Cell Migration, Invasion and Aerobic Glycolysis of Esophageal Squamous Cell Carcinoma Cells via miR-765/PDX1 Axis.

Authors:  Cui-Juan Qian; Zhu-Rong Xu; Lu-Yan Chen; Yi-Chao Wang; Jun Yao
Journal:  Cancer Manag Res       Date:  2020-08-05       Impact factor: 3.989

5.  Long non-coding RNA GATA6-AS1 upregulates GATA6 to regulate the biological behaviors of lung adenocarcinoma cells.

Authors:  Honggang Kang; Dan Ma; Jing Zhang; Jun Zhao; Mengxiang Yang
Journal:  BMC Pulm Med       Date:  2021-05-15       Impact factor: 3.320

6.  lncRNA MAFG-AS1 Contributes to Esophageal Squamous-Cell Carcinoma Progression via Regulating miR143/LASP1.

Authors:  Yunhui Qu; Jinbo Liu
Journal:  Onco Targets Ther       Date:  2020-08-20       Impact factor: 4.147

7.  Silencing of LINC00284 inhibits cell proliferation and migration in oral squamous cell carcinoma by the miR-211-3p/MAFG axis and FUS/KAZN axis.

Authors:  Dayong Yan; Fuhua Wu; Caixia Peng; Mei Wang
Journal:  Cancer Biol Ther       Date:  2021-02-22       Impact factor: 4.742

8.  LncRNA MAFG-AS1 promotes the malignant phenotype of ovarian cancer by upregulating NFKB1-dependent IGF1.

Authors:  Yang Bai; Chenchen Ren; Baojin Wang; Jingge Xue; Feiyan Li; Jiaxi Liu; Li Yang
Journal:  Cancer Gene Ther       Date:  2021-05-25       Impact factor: 5.987

9.  THBS2, a microRNA-744-5p target, modulates MMP9 expression through CUX1 in pancreatic neuroendocrine tumors.

Authors:  Heng Jiao; Lingxiao Zeng; Jianpeng Zhang; Shengsheng Yang; Wenhui Lou
Journal:  Oncol Lett       Date:  2020-01-09       Impact factor: 2.967

10.  Characterization of a non-coding RNA-associated ceRNA network in metastatic lung adenocarcinoma.

Authors:  Feifei Fan; Yu Ping; Li Yang; Xiaoran Duan; Nomathamsanqa Resegofetse Maimela; Bingjie Li; Xiangnan Li; Jing Chen; Kai Zhang; Liping Wang; Shasha Liu; Xuan Zhao; Hongmin Wang; Yi Zhang
Journal:  J Cell Mol Med       Date:  2020-08-29       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.